CVS Health controversies

Public question raised over whether CVS Health Corporation insiders breached fiduciary duties to shareholders

Issue disclosure

A PR Newswire release titled "Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?" publicly raised the question of whether insiders of CVS Health Corporation breached fiduciary duties owed to shareholders. The supplied material consists only of the headline; it does not identify the party that raised the question, does not describe the conduct at issue, and does not state any finding, conclusion, or determination. No regulatory or judicial outcome is reported in the available text. The item is dated September 26, 2026, and is attributed to a PR Newswire distribution. Because no further details are provided, this note records only that the question was publicly posed regarding CVS Health insiders and their fiduciary duties to shareholders.

A PR Newswire release headlined "Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?" publicly raised the question of whether CVS Health Corporation insiders breached fiduciary duties owed to shareholders. The supplied text consists only of the headline and does not identify who raised the question, the underlying conduct, or any determination.

University of Kentucky sues CVS Health

Lawsuit filed

The University of Kentucky filed suit against CVS Health Corporation in federal court, alleging civil racketeering, fraud and breach of contract. According to the university, the company diverted approximately $41 million in 340B prescription revenue over a five-year period. The university is seeking damages under the RICO Act.

The University of Kentucky sued CVS Health Corporation in federal court, alleging civil racketeering, fraud and breach of contract, and claiming that the company diverted around $41 million in 340B prescription revenue over five years. The university is seeking damages under the RICO Act.

Opioid-crisis liability finding

A federal jury found CVS, Walgreens, and Walmart substantially contributed to the opioid crisis in two Ohio counties. The finding formed part of extensive litigation concerning pharmacy dispensing practices and the public-health effects of prescription opioids.

CVS Health controversy: CVS suspends sales of Zantac and ranitidine products

Corrective action

CVS Pharmacy said it suspended sales of Zantac-brand and CVS Health-brand ranitidine products until further notice after an FDA alert that ranitidine products may contain a possible human carcinogen. The source says the products had not been recalled and the FDA was not recommending that patients stop taking them.

Caremark health and Medicare fraud cases

Caremark, which later became part of the CVS Caremark structure, faced health-fraud and Medicare-fraud controversies in the late 1980s and early 1990s. The referenced material states that related settlements with the U.S. government exceeded $250 million in aggregate.